Neovacs
Biotech firm developing immunotherapies and investing in BioTech and MedTech.
ALNEV | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- FR0004032746 (+4 more)
- LEI:
- 9695001J9GMM5XYK6482
- Country:
- France
- Address:
- 14 RUE DE LA REPUBLIQUE, 92150 SURESNES
- Website:
- https://www.neovacs.com/en/
Description
Neovacs is a biotechnology company with two main activities: research and development, and investment. The company's R&D focuses on its proprietary Kinoid technology platform, an active immunotherapy approach for treating autoimmune diseases and allergies. This technology develops therapeutic vaccines designed to stimulate the patient's immune system to regulate the overproduction of harmful cytokines. Key indications for its Kinoid products include lupus. In addition to its internal development, Neovacs invests in high-potential BioTech and MedTech companies, leveraging its experienced team to evaluate and support innovative products and medical devices.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-11-13 18:00 |
NÉOVACS SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE
|
French | 184.0 KB | ||
| 2019-11-13 18:00 |
NEOVACS REQUESTS A REORGANIZATION PROCEEDINGS OF THE COMPANY
|
English | 182.9 KB | ||
| 2019-11-08 20:05 |
POINT SUR LA SITUATION FINANCIÈRE DE LA SOCIÉTÉ ET SUSPENSION DU COURS DE BOUR…
|
French | 162.1 KB | ||
| 2019-10-31 15:55 |
NEOVACS : RAPPORT FINANCIER SEMESTRIEL 2019
|
French | 3.6 MB | ||
| 2019-10-30 17:45 |
MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2019
|
French | 183.0 KB | ||
| 2019-10-30 14:32 |
NEOVACS : RAPPORT FINANCIER SEMESTRIELS
|
French | 1.8 MB | ||
| 2019-09-09 17:45 |
Néovacs : Agenda financier 2019
|
French | 138.3 KB | ||
| 2019-09-09 17:45 |
Neovacs : 2019 Financial Calendar
|
English | 99.3 KB | ||
| 2019-07-09 07:30 |
NÉOVACS REÇOIT LE PREMIER VERSEMENT DE LA SUBVENTION ANR SUITE À LA PRÉSENTATIO…
|
French | 486.4 KB | ||
| 2019-06-27 07:30 |
NÉOVACS ANNONCE LA NOMINATION DU Dr. VIRGINIA PASCUAL EN TANT QUE CONSEILLÈRE M…
|
French | 767.6 KB | ||
| 2019-06-27 07:30 |
NEOVACS ANNOUNCES THE APPOINTMENT of Dr. VIRGINIA PASCUAL AS MEDICAL AND SCIENT…
|
English | 753.2 KB | ||
| 2019-06-05 07:30 |
Néovacs présente les résultats précliniques de l'IFNalpha Kinoïde pour le trait…
|
French | 208.0 KB | ||
| 2019-06-05 07:30 |
Neovacs to present the pre-clinical results of its IFNalpha Kinoid to treat typ…
|
English | 179.9 KB | ||
| 2019-06-03 17:56 |
Néovacs annonce avoir réuni son Assemblée Générale Mixte sur seconde convocatio…
|
French | 142.6 KB | ||
| 2019-05-23 07:30 |
NÉOVACS PROCÈDE AUX TIRAGES DE LA SECONDE TRANCHE PRÉVUE PAR SON PROGRAMME DE F…
|
French | 227.6 KB |
Automate Your Workflow. Get a real-time feed of all Neovacs filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Neovacs
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Neovacs via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
